CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells
Open Access
- 3 July 2008
- journal article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 27 (1), 15-12
- https://doi.org/10.1186/1756-9966-27-15
Abstract
Background The cellular apoptosis susceptibility (CAS) protein is regarded as a proliferation-associated protein that associates with tumour proliferation as it associates with microtubule and functions in the mitotic spindle checkpoint. However, there is no any actual experimental study showing CAS (or CSE1 and CSE1L) can increase the proliferation of cancer cells. Previous pathological study has reported that CAS was strongly positive stained in all of the metastasis melanoma that be examined. Thus, CAS may regulate the invasion and metastasis of cancers. CAS is highly expressed in cancers; if CAS is associated with cancer proliferation, then increased CAS expression should be able to increase the proliferation of cancer cells. We studied whether increased CAS expression can increase cancer cell proliferation and whether CAS regulates the invasion of cancer cells. Methods We enhanced or reduced CAS expression by transfecting CAS or anti-CAS expression vectors into human MCF-7 breast cancer cells. The proliferations of cells were determined by trypan blue exclusion assay and flow cytometry analysis. Invasion of cancer cells were determined by matrigel-based invasion assay. Results Our studies showed that increased CAS expression was unable to enhance cancer cell proliferation. Immunofluorescence showed CAS was distributed in cytoplasm areas near cell membrane and cell protrusions. CAS was localized in cytoplasmic vesicle and immunogold electronmicroscopy showed CAS was located in vesicle membrane. CAS overexpression enhanced matrix metalloproteinase-2 (MMP-2) secretion and cancer cell invasion. Animal experiments showed CAS reduction inhibited the metastasis of B16-F10 melanoma cells by 56% in C57BL/6 mice. Conclusion Our results indicate that CAS increases the invasion but not the proliferation of cancer cells. Thus, CAS plus ECM-degradation proteinases may be used as the markers for predicting the advance of tumour metastasis.Keywords
This publication has 35 references indexed in Scilit:
- The p53 tumor suppressor participates in multiple cell cycle checkpointsJournal of Cellular Physiology, 2006
- Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancerOncogene, 2005
- Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressorsPublished by Cold Spring Harbor Laboratory ,2004
- CAS/CSE 1 stimulates E-cadhrin-dependent cell polarity in HT-29 human colon epithelial cellsBiochemical and Biophysical Research Communications, 2002
- Cse1l Is Essential for Early Embryonic Growth and DevelopmentMolecular and Cellular Biology, 2001
- Cellular Apoptosis Susceptibility Gene Expression in Endometrial Carcinoma: Correlation With Bcl-2, Bax, and Caspase-3 Expression and OutcomeInternational Journal of Gynecological Pathology, 2001
- Posttranscriptional Stimulation of Endothelial Cell Matrix Metalloproteinases 2 and 1 by Endothelioma CellsExperimental Cell Research, 2000
- Export of Importin α from the Nucleus Is Mediated by a Specific Nuclear Transport FactorCell, 1997
- Antisense Inhibition of CAS, the Human Homologue of the Yeast Chromosome Segregation Gene CSE1, Interferes with Mitosis in HeLa CellsBiochemistry, 1997
- Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinomaInternational Journal of Cancer, 1994